UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
IPO Year:
Exchange: NYSE
Website: unitedhealthgroup.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/21/2025 | $270.00 | Hold → Reduce | HSBC Securities |
| 5/19/2025 | $308.00 | Buy → Hold | TD Cowen |
| 5/14/2025 | Strong Buy → Mkt Perform | Raymond James | |
| 5/14/2025 | $350.00 | Buy → Neutral | BofA Securities |
| 4/22/2025 | $490.00 | Buy → Hold | HSBC Securities |
| 4/21/2025 | Buy → Hold | Argus | |
| 1/10/2025 | $595.00 | Hold → Buy | HSBC Securities |
| 1/6/2025 | $625.00 → $610.00 | Buy | Truist |
| 10/17/2024 | Buy → Hold | HSBC Securities | |
| 10/11/2024 | $675.00 | Overweight | KeyBanc Capital Markets |
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
DEF 14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
S-8 - UNITEDHEALTH GROUP INC (0000731766) (Filer)
10-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr
Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company
CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa
Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well
UnitedHealth Group (NYSE:UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technol
Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients. Effective immediately and with full implementation by January 2028, Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. This change will positively impact Optum Rx non-affiliated network pharmacies, including the more than 24,000 independent, community pharmacies we serve. These cost-based payment models will also provide more consistently affordable experiences for consumers. With this change, Optum Rx is addressing a legacy, industry-w
Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations. "Optum Rx is taking meaningful steps to simplify patient experiences and increase access to critical medications," said Patrick Conway, M.D., chief executive officer, Optum Rx "These changes mean easier access to medications for consumers, less work for pharmacists and physicians, and a simplified system focused on clinical quality." The initiative focuses first on approximately 80 drugs, and Optum Rx will work with physicians and pha
AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health b
The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry's highest levels on those reviews. We are not aware of the "launch" of any "new" activity as reported by the Journal. We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions. Any suggestion that our practices are fraudulent is outrageous and false. View source version on businesswire.com: https://www.businesswire.com/news/home/20250221143102/en/ uh
Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company
Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well
AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health b
Revenues of $400.3 Billion Grew 8% Year-Over-Year Domestic Consumers Served by UnitedHealthcare Grew 2.1 Million Value-Based Care Patients Served by Optum Grew 600,000 Cash Flows from Operations were $24.2 Billion or 1.6x Net Income Full Year, Fourth Quarter Net Earnings were $15.51, $5.98 Per Share Full Year, Fourth Quarter Adjusted Net Earnings were $27.66, $6.81 Per Share Company Affirms 2025 Performance Outlook UnitedHealth Group (NYSE:UNH) reported full year and fourth quarter 2024 results reflecting diversified growth in serving people more extensively at Optum and UnitedHealthcare. "The people of UnitedHealth Group remain focused on making high-quality, afford
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on December 17, 2024, to all shareholders of record of UNH common stock as of the close of business December 9, 2024. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of hea
Revenues of $100.8 Billion Grew $8.5 Billion Year Over Year Consumers Served by UnitedHealthcare's Commercial Domestic Offerings Grew 2.4 Million Year to Date Third Quarter Earnings of $6.51 Per Share Include Cyberattack Impacts Adjusted Earnings of $7.15 Per Share Include $0.12 in Business Disruption Impacts; Exclude $0.28 Direct Response Costs UnitedHealth Group (NYSE:UNH) reported third quarter 2024 results reflecting broad-based growth in the number of people served by Optum and UnitedHealthcare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241015234962/en/UnitedHealth Group corporate headquarters (Photo: Business
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on September 24, 2024, to all shareholders of record of UNH common stock as of the close of business September 16, 2024. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range o
AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is stable. The proceeds from UnitedHealth Group's recent $12 billion debt issuance are expected to be used for general corporate purposes, including repayment of outstanding commercial paper. At June 30, 2024, the company had approximately $10 billion of commercial paper outstanding. Financial leverage, as measured by AM Best, was approximately 44% at the end of second-quarter 2024. These debt issua
Revenues of $98.9 Billion Grew Nearly $6 Billion Year Over Year, Led by Optum Consumers Served by UnitedHealthcare's Commercial Domestic Offerings Grew 2.3 Million Year to Date Cash Flows from Operations were $6.7 Billion or 1.5x Net Income Second Quarter Earnings of $4.54 Per Share Reflect Classification of Remaining South American Operations as Held for Sale and Cyberattack Impacts Adjusted Earnings of $6.80 Per Share Include $0.28 in Business Disruption Impacts; Exclude South American and Direct Response Costs UnitedHealth Group (NYSE:UNH) reported second quarter 2024 results reflecting broad-based growth at Optum and UnitedHealthcare. This press release features multime
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
3 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00
TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00
Raymond James downgraded UnitedHealth from Strong Buy to Mkt Perform
BofA Securities downgraded UnitedHealth from Buy to Neutral and set a new price target of $350.00
HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00
Argus downgraded UnitedHealth from Buy to Hold
HSBC Securities upgraded UnitedHealth from Hold to Buy and set a new price target of $595.00
Truist reiterated coverage of UnitedHealth with a rating of Buy and set a new price target of $610.00 from $625.00 previously
HSBC Securities downgraded UnitedHealth from Buy to Hold
KeyBanc Capital Markets initiated coverage of UnitedHealth with a rating of Overweight and set a new price target of $675.00
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr
UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos
Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol
MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. "Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting, and business strategy, including extensive senior leadership experience at multiple Fortune 500 companies, leading large divisions within the healthcare, consumer and retail industries," said Da
Pali Bhat, leading technologist at Reddit and formerly Google, recruited by company to join Board Kevin Galligan and Susan D. Arthur appointed to Board in connection with an agreement with JANA Partners LLC New Relic (NYSE:NEWR), the observability company, today announced several updates related to its Board of Directors. As the result of its ongoing board refreshment process, New Relic has appointed Pali Bhat to the Board of Directors, effective June 13, 2022. Mr. Bhat brings to New Relic's Board more than 15 years of expertise in leading teams and products across consumer services, developer platforms, fintech, and cloud. He has served as the Chief Product Officer of Reddit, Inc since
Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nation's leaders in high-quality dermatology, today announced the appointment of David Loschinskey as Executive Vice President of Operations. Mr. Loschinskey most recently founded 8th Day Labs to provide executive services to small and midsize companies with a wide range of services, including executive mentoring, operational planning and optimization, technology strategic planning, and mergers and acquisitions diligence services. 8th Day Labs is a sequel to 8th Day Software, which Mr. Loschinskey also founded and served as CEO in 2013. 8th Day Software satisfied a market need for reliable and cost-effective health care-related s
London, April 26, 2021 CNH Industrial N.V. (NYSE:CNHI) today announced that it has appointed Parag Garg as Chief Digital Officer and Marc Kermisch as Chief Information Officer for Off Highway business. This follows the appointment of Kevin Barr as Chief Human Resources Officer on March 19, 2021. In these positions, Mr. Garg, Mr. Kermisch and Mr. Barr will join the Company's Senior Leadership Team (SLT), an operational decision-making body of CNH Industrial, which is responsible for reviewing the operating performance of the segments and making decisions on certain operational matters. These executive appointments form part of CNH Industrial's renewed focus on customer centricity and serve
EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone. This combination unites two technology and service companies focused on serving health care. Their combined capabilities will more effectively connect and simplify core clinical, administrative and payment processes - resu